Mutations in the U2AF1 gene have been described in a wide range of cancers, including myelodysplastic syndrome, acute myeloid leukaemia, primary myelofibrosis, chronic myelomonocytic leukaemia, hairy cell leukaemia and various solid tumours [4]. This evidence concerns the gene U2AF1 and monocytic leukemia.